SCHEMBL19458562

SCHEMBL19458562

CCC(CC)CNCCCNCCCN

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.50
CA6 P23280 4/20 0.50
CA7 P43166 4/20 0.50
CA9 Q16790 4/20 0.50
CA14 Q9ULX7 4/20 0.50
CA5B Q9Y2D0 4/20 0.50
CA2 P00918 3/20 0.50
CA4 P22748 3/20 0.50
CA5A P35218 3/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
CASP2 P42575 2/20 0.50
F13A1 P00488 2/20 0.50
CYP1A2 P05177 2/20 0.50
ALOX15 P16050 2/20 0.50
THPO P40225 2/20 0.50
CYP2C19 P33261 2/20 0.50
RECQL P46063 2/20 0.50
HSD17B10 Q99714 1/20 0.50
CA3 P07451 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21799969 0.96 CA12 (0.48) CA12CA6CA7CA9CA14
SCHEMBL23468508 0.91 CA12 (0.48) CA12CA6CA7CA9CA14
SCHEMBL21799824 0.89 CA12 (0.50) CA12CA6CA7CA9CA14
SCHEMBL10045097 0.89 ALDH1A1 (0.48) CA12CA6CA7CA9CA14
SCHEMBL21799740 0.87 TSHR (0.48) CA12CA6CA7CA9CA14
SCHEMBL21799671 0.87 TSHR (0.48) CA12CA6CA7CA9CA14
SCHEMBL21799731 0.87 TSHR (0.48) CA12CA6CA7CA9CA14
SCHEMBL21799895 0.87 TSHR (0.48) CA12CA6CA7CA9CA14
SCHEMBL21799521 0.87 TSHR (0.48) CA12CA6CA7CA9CA14
SCHEMBL21799641 0.87 TSHR (0.48) CA12CA6CA7CA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3606344-B1 COMPOSITIONS AND METHODS COMPRISING A TRIARYL POLYAMINE CURZA GLOBAL LLC (US) 2022-08-17 EP disclosed
US-11352315-B2 Compositions and methods comprising a triaryl polyamine CURZA GLOBAL, LLC (US) 2022-06-07 US disclosed
CN-110785082-B Compositions and methods comprising triarylpolyamines 库扎环球有限责任公司 2021-12-28 CN disclosed
CN-110785082-A Compositions and methods comprising triarylpolyamines 库扎环球有限责任公司 2020-02-11 CN disclosed
US-20200031757-A1 COMPOSITIONS AND METHODS COMPRISING A TRIARYL POLYAMINE CURZA GLOBAL, LLC (US) 2020-01-30 US disclosed
US-20170298002-A1 METHOD OF PRODUCING N-ALKYL POLYAMINES CURZA GLOBAL, LLC 2017-10-19 US disclosed
US-20170298002-A1 METHOD OF PRODUCING N-ALKYL POLYAMINES CURZA GLOBAL, LLC 2017-10-19 US disclosed
US-20170298002-A1 METHOD OF PRODUCING N-ALKYL POLYAMINES CURZA GLOBAL, LLC 2017-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11352315-B2 Compositions and methods comprising a triaryl polyamine SRM, PARG, PARN CA12 4744/4885CA6 4331/4885CA7 3797/4885
US-20200031757-A1 COMPOSITIONS AND METHODS COMPRISING A TRIARYL POLYAMINE SRM, PARG, PARN CA12 4744/4885CA6 4331/4885CA7 3797/4885
US-20170298002-A1 METHOD OF PRODUCING N-ALKYL POLYAMINES SRM, PNMT, SMS CA12 2715/4885CA6 1846/4885CA7 2566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.